These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 26499949

  • 1. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B, Li M, Zhang L, Huang M, Lei JB, Fu GH, Liu CX, Lai QW, Chen QQ, Wang YL.
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [Abstract] [Full Text] [Related]

  • 2. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J.
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [Abstract] [Full Text] [Related]

  • 3. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
    Wang Q, Chen Q.
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697
    [Abstract] [Full Text] [Related]

  • 4. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [Abstract] [Full Text] [Related]

  • 5. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L, Lv J, Zhang Y, Li J, Wang Y, Yang H.
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [Abstract] [Full Text] [Related]

  • 6. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma.
    Wen JJ, Ma YD, Yang GS, Wang GM.
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):498-503. PubMed ID: 28239821
    [Abstract] [Full Text] [Related]

  • 7. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ, Guo XJ, Zhao YM, Fang Y.
    Int J Clin Exp Pathol; 2015 Feb; 8(11):15138-42. PubMed ID: 26823857
    [Abstract] [Full Text] [Related]

  • 8. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N, Zhou Q, Qi YH, Wang H, Yang L, Fan QY.
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X, Zhang L, Zhao F, Xu R, Jiang J, Zhang C, Liu H, Huang H.
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [Abstract] [Full Text] [Related]

  • 10. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF, Dai ZT, Liu WD, Zhao ZX, Kong YH.
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [Abstract] [Full Text] [Related]

  • 11. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W, He X, Xue R, Zhang Y, Zhang X, Lu J, Zhang Z, Xue L.
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
    Xie CH, Cao YM, Huang Y, Shi QW, Guo JH, Fan ZW, Li JG, Chen BW, Wu BY.
    Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH, Yang LB, Geng XL, Wang R, Zhang ZC.
    Int J Clin Exp Pathol; 2015 Nov; 8(3):2994-3000. PubMed ID: 26045809
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F, Cao L, Hang D, Wang F, Wang Q.
    Int J Clin Exp Pathol; 2015 Nov; 8(9):11414-20. PubMed ID: 26617868
    [Abstract] [Full Text] [Related]

  • 15. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y, Li Q, Wang X, Jiao X, Zheng J, Li Z, Pan X.
    Oncotarget; 2017 Jul 18; 8(29):46993-47006. PubMed ID: 28388584
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Liu W, Zhao X, Zhang YJ, Fang GW, Xue Y.
    J Int Med Res; 2018 Mar 18; 46(3):975-983. PubMed ID: 29115164
    [Abstract] [Full Text] [Related]

  • 17. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q, Song S, Ni G, Li Y, Wang X.
    Cancer Biomark; 2018 Feb 14; 21(3):521-526. PubMed ID: 29103020
    [Abstract] [Full Text] [Related]

  • 18. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X, Shen Y, Zheng S, Liu J, Jiang X.
    Br J Biomed Sci; 2016 Oct 14; 73(4):158-162. PubMed ID: 27922432
    [Abstract] [Full Text] [Related]

  • 19. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z, Tan M, Chen G, Li Z, Lu X.
    IUBMB Life; 2017 Nov 14; 69(11):867-876. PubMed ID: 28960757
    [Abstract] [Full Text] [Related]

  • 20. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B, Tu J, Yin J, Zou C, Wang J, Huang G, Xie X, Shen J.
    Oncotarget; 2015 Nov 10; 6(35):38348-59. PubMed ID: 26435480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.